Background The Patient Protection and Affordable Care Act of 2010 added a new Medicare benefit, the Annual Wellness Visit (AWV), effective January 1, 2011. One of the requirements of the AWV is the detection of any cognitive impairment. The Alzheimer's Association convened a workgroup of ...
Your first Medicare annual wellness visit will be more thorough than later ones. It will include establishing a baseline regarding your physical and mental health history, risk factors, and any signs of cognitive impairment. You'll also set up a personalized screening schedule going forward. The d...
Cognitive screening often falls by the wayside: Medicare pays for wellness visits that include dementia screening; time constraints pose obstacle.(PRACTICE TRENDS)Schneider, Mary Ellen
THE MEDICARE ANNUAL WELLNESS VISIT AS AN OPPORTUNITY FOR IMPROVING DETECTION OF COGNITIVE IMPAIRMENT: THE EXPERIENCE OF A LARGE MIDWESTERN HEALTH SYSTEMTwo distinct views of the roles and responsibilities of epidemiologists have emerged in a decades-long debate: one keeps professional practice constrained...
Medicare Annual Wellness VisitObjective To evaluate the relationship between direct cognitive assessment introduced with the Medicare Annual Wellness Visit (AWV) and new diagnoses of dementia, and to determine if effects vary by race.Lind, Kimberly E.Hildreth, KerryLindrooth, RichardMorrato, Elaine...
Objectives To examine the effect of the Medicare Annual Wellness Visit (AWV) on the detection of cognitive impairment and on follow‐up cognitive care for older adults. Design Retrospective matched‐cohort study. Setting United States. Participants A 5% random sample of fee‐for‐service Medicare ...
Background: Cognitive assessment is a required component of the Medicare Annual Wellness Visit (AWV). In this prospective study, we evaluated acceptability and usefulness of a patient-reported outcome measure (the PROMIS Cognitive Function Screener, or PRO-CS) to screen for cognitive impairment ...
Cognitive Screening Before the Medicare Annual Wellness VisitKatherine R. BrooksValerie K. SabolKatie Peters SettjeTracey L. Yap
Screening for cognitive impairment is not currently recommended due to lack of studies demonstrating benefit. HealthPartners piloted using the Mini-Cog to screen patients aged ≥ 65 years, and physicians expressed concern about the...doi:10.1016/j.jalz.2017.06.1140Rosenbloom, Michael H....